Dana Gelbaum is currently the Operations & Product Team Lead for AL102 at Immunome, Inc., a role they began in 2024. They have held various leadership positions, including Chief Commercial Officer at Bioblast Pharma from 2016 to 2017, and General Manager & Chief Business Officer at Ayala Pharmaceuticals from 2023 to 2024. Previously, Dana served as Director of Business Development at Recoly NV and held multiple roles at Johnson & Johnson Development Corporation, including Associate from 2003 to 2007. With dual degrees in Molecular and Cellular Biology and Finance from Tel Aviv University, Dana has a strong educational background to support their extensive experience in the biopharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices